Zobrazeno 1 - 10
of 18
pro vyhledávání: '"Kevin McFarthing"'
Autor:
Amit Khanna, Jamie Adams, Chrystalina Antoniades, Bastiaan R. Bloem, Camille Carroll, Jesse Cedarbaum, Joshua Cosman, David T. Dexter, Marissa F. Dockendorf, Jeremy Edgerton, Laura Gaetano, Erkuden Goikoetxea, Derek Hill, Fay Horak, Elena S. Izmailova, Tairmae Kangarloo, Dina Katabi, Catherine Kopil, Michael Lindemann, Jennifer Mammen, Kenneth Marek, Kevin McFarthing, Anat Mirelman, Martijn Muller, Gennaro Pagano, M. Judith Peterschmitt, Jie Ren, Lynn Rochester, Sakshi Sardar, Andrew Siderowf, Tanya Simuni, Diane Stephenson, Christine Swanson-Fischer, John A. Wagner, Graham B. Jones
Publikováno v:
npj Parkinson's Disease, Vol 10, Iss 1, Pp 1-9 (2024)
Abstract Parkinson’s Disease is a progressive neurodegenerative disorder afflicting almost 12 million people. Increased understanding of its complex and heterogenous disease pathology, etiology and symptom manifestations has resulted in the need to
Externí odkaz:
https://doaj.org/article/618ab6ef31f24f8996de46c4c52bb9ee
Publikováno v:
Journal of Parkinson's Disease. 12:523-536
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::1a5e9f16fdb972d33f17dc5d5d0dc2d4
https://doi.org/10.3233/jpd-229001
https://doi.org/10.3233/jpd-229001
Autor:
Kevin McFarthing
Publikováno v:
Journal of Parkinson's disease. 12(8)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d1ab602d7ea9975a101a3c035b6985c8
https://pubmed.ncbi.nlm.nih.gov/36373296
https://pubmed.ncbi.nlm.nih.gov/36373296
Publikováno v:
Journal of Parkinson's Disease
Background: Despite the COVID-19 pandemic, there has been considerable activity in the clinical development of novel and improved drug-based therapies for the neurodegenerative condition of Parkinson’s disease (PD) during 2020. The agents that were
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::db8aff13ce1faec137a9e07dcbb637e6
https://doi.org/10.3233/jpd-219006
https://doi.org/10.3233/jpd-219006
Autor:
Alberto J. Espay, Kevin McFarthing
Publikováno v:
Parkinsonism & Related Disorders. :105432
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::c10f5e04bc8d0610bc755b30af53c135
https://doi.org/10.1016/j.parkreldis.2023.105432
https://doi.org/10.1016/j.parkreldis.2023.105432
Autor:
Kevin McFarthing, Gary Rafaloff, Marco Baptista, Leah Mursaleen, Rosie Fuest, Richard K. Wyse, Simon R.W. Stott
Publikováno v:
Journal of Parkinson's disease. 12(4)
Background: As the international community dealt with the ongoing COVID-19 pandemic, important progress continued to be made in the development of new drug-based therapies for the neurodegenerative condition of Parkinson’s disease (PD) in 2021. Thi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4a7620b9a72507592e11f16d32b48d7e
https://pubmed.ncbi.nlm.nih.gov/35527571
https://pubmed.ncbi.nlm.nih.gov/35527571
Publikováno v:
Journal of Parkinson's Disease
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6acddbc71c6bc1b76513d0b3df420339
http://europepmc.org/articles/PMC7029325
http://europepmc.org/articles/PMC7029325
Publikováno v:
Journal of Parkinson's Disease. 11:391-393
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::119f3c743dde8849bf4ffe0ea3aa09ff
https://doi.org/10.3233/jpd-219004
https://doi.org/10.3233/jpd-219004
Publikováno v:
Journal of Parkinson's Disease
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ea212aebe55ab31db87d5485fbbc4ac6
https://doi.org/10.3233/jpd-199002
https://doi.org/10.3233/jpd-199002
Autor:
Marie-Louise Zeissler, Kevin McFarthing, Cristina Gonzalez-Robles, Rebecca Chapman, Georgia Mills, Tom Foltynie, Camille Carroll
Publikováno v:
Journal of Neurology, Neurosurgery & Psychiatry. 93:e2.61
BackgroundPatient-centred trials address patient relevant questions, have protocols that maximise recruitment and retention, as well as effective communication strategies. Involving patients and carers in trial design and oversight is essential for p
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::6bcf696c522d83892c74fa3f55cf9d1d
https://doi.org/10.1136/jnnp-2022-abn2.153
https://doi.org/10.1136/jnnp-2022-abn2.153